Cart
sales@molnova.com
EBPC
CAS No. 4450-98-0
EBPC( —— )
Catalog No. M27626 CAS No. 4450-98-0
EBPC is an inhibitor of aldose reductase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 159 | Get Quote |
|
| 10MG | 241 | Get Quote |
|
| 25MG | 435 | Get Quote |
|
| 50MG | 622 | Get Quote |
|
| 100MG | 885 | Get Quote |
|
| 500MG | 1764 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEBPC
-
NoteResearch use only, not for human use.
-
Brief DescriptionEBPC is an inhibitor of aldose reductase.
-
DescriptionEBPC is an inhibitor of aldose reductase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorAkt|Bcl-2|Caspase|ERK|IL Receptor|JAK|JNK|mTOR|NF-κB|p38 MAPK|PI3K|STAT|TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4450-98-0
-
Formula Weight261.277
-
Molecular FormulaC14H15NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)C1=C(O)C(=O)N(Cc2ccccc2)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ma X, et al. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways. Biochem Biophys Res Commun. 2014 Mar 7;445(2):282-8.
molnova catalog
related products
-
CH5138303
CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
-
Ganoderic acid C2
Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on the induction of Epstein-Barr Virus early antigen.
-
Saikosaponin B2
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells.
